MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4
- Type
- Reinstatement
- Notice date
- 2/1/2024 0:00
- Journal
- Bioengineered
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1080/21655979.2024.2302650
- Original paper DOI
- 10.1080/21655979.2021.1997697
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Human Subject Welfare
- Unreliable Data
- Unreliable Results and/or Conclusions